MIRM vs. CORT
MIRM (Mirum Pharmaceuticals, Inc.) and CORT (Corcept Therapeutics Incorporated) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, MIRM returned 48.95%/yr vs 40.69%/yr for CORT. Their 0.26 correlation means their historical movements had little consistent relationship.
Performance
MIRM vs. CORT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MIRM achieves a 34.13% return, which is significantly lower than CORT's 228.99% return.
MIRM
- 1D
- -5.90%
- 1M
- -15.64%
- 6M
- 2.64%
- YTD
- 34.13%
- 1Y
- 103.67%
- 3Y*
- 61.89%
- 5Y*
- 48.95%
- 10Y*
- —
- ALL TIME*
- 34.74%
CORT
- 1D
- -3.24%
- 1M
- 26.91%
- 6M
- 187.16%
- YTD
- 228.99%
- 1Y
- 65.93%
- 3Y*
- 66.06%
- 5Y*
- 40.69%
- 10Y*
- 35.35%
- ALL TIME*
- 10.54%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $163.77M | $133.02M | $94.73M | |
| $68.27M | $72.48M | $108.55M |
MIRM vs. CORT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
MIRM Mirum Pharmaceuticals, Inc. | 34.13% | 91.03% | 40.07% | 51.38% | 22.26% | -8.65% | -28.79% | 88.62% |
CORT Corcept Therapeutics Incorporated | 228.99% | -30.94% | 55.14% | 59.92% | 2.58% | -24.31% | 116.20% | 13.40% |
Correlation
The correlation between MIRM and CORT is 0.35, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.35 |
Correlation (3Y) Balances recent behavior with more history. | 0.30 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.28 |
Correlation (All Time) Calculated using the full available price history since Jul 18, 2019 | 0.26 |
Fundamentals
MIRM:
$6.46B
CORT:
$12.29B
MIRM:
-$14.43
CORT:
$0.48
MIRM:
14.31
CORT:
15.92
MIRM:
25.71
CORT:
19.20
MIRM:
$409.73M
CORT:
$830.81M
MIRM:
-$422.68M
CORT:
$816.73M
MIRM:
-$771.51M
CORT:
$23.30M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MIRM vs. CORT — Risk / Return Rank
MIRM
CORT
MIRM vs. CORT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Mirum Pharmaceuticals, Inc. (MIRM) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MIRM | CORT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.40 | ||
| Sortino ratioReturn per unit of downside risk | +1.23 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.31 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 5.14 | 1.10 | +4.04 |
| Martin ratioReturn relative to average drawdown | 11.27 | 2.01 | +9.27 |
Loading charts...
Drawdowns
MIRM vs. CORT - Drawdown Comparison
The maximum MIRM drawdown since its inception was -63.78%, smaller than the maximum CORT drawdown of -94.29%. Use the drawdown chart below to compare losses from any high point for MIRM and CORT.
Loading charts...
Drawdown Indicators
| MIRM | CORT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.78% | -94.29% | +30.51% |
Max Drawdown (1Y)Largest decline over 1 year | -20.55% | -64.40% | +43.85% |
Max Drawdown (3Y)Largest decline over 3 years | -32.52% | -71.85% | +39.33% |
Max Drawdown (5Y)Largest decline over 5 years | -40.25% | -71.85% | +31.60% |
Max Drawdown (10Y)Largest decline over 10 years | — | -71.85% | — |
Current DrawdownCurrent decline from peak | -17.59% | -3.24% | -14.35% |
Average DrawdownAverage peak-to-trough decline | -19.97% | -53.26% | +33.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.35% | 35.24% | -25.89% |
Volatility
MIRM vs. CORT - Volatility Comparison
The current volatility for Mirum Pharmaceuticals, Inc. (MIRM) is 13.55%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 28.47%. This indicates that MIRM experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MIRM | CORT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.55% | 28.47% | -14.92% |
Volatility (6M)Calculated over the trailing 6-month period | 36.27% | 48.65% | -12.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.62% | 82.04% | -35.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 51.81% | 75.77% | -23.96% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.58% | 67.83% | +5.75% |
Dividends
MIRM vs. CORT - Dividend Comparison
Neither MIRM nor CORT has paid dividends to shareholders.
Financials
MIRM vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Mirum Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MIRM and CORT have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CORT has higher volatility (28.47%) compared to MIRM (13.55%). In terms of maximum drawdown, MIRM dropped -63.78% vs CORT's -94.29%.
MIRM currently has the higher Sharpe Ratio (2.27 vs 0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MIRM and CORT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer